Appointments at Roche, Caraco, CMP Therapeutics and Unilife – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Chief operating officer Medicine Pharmacology Ceo

in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Roche, Caraco, CMP Therapeutics and Unilife.

GP Singh Sachdeva ​has been promoted to the position of chief operating officer at Caraco Pharmaceutical Laboratories​. Sachdeva has worked at Caraco since 2000, holding a number of positions.

Roche ​has appointed Karen Lackey ​as vice president (VP) and head of medicinal chemistry. Lackey last worked at GlaxoSmithKline and has also held positions at Pfizer.

Neill Moray Mackenzie ​as been named as CEO of CMP Therapeutics​. Mackenzie has executive level experience at biopharm firms including Cambridge Genetics, Oxford Biomedica and Medigene AG.

CT Atlantic AG ​has hired Michael Höcker​ as CEO and Cara Lerner ​as chief operating officer. Höcker has previously worked at Roche and AstraZeneca. Lerner joined CT Atlantic in 2009 having previously worked at Merck & Co.

Marc Firestone ​has joined the board of directors and strategic partnerships committee at Unilife​. Firestone works at Kraft Foods and has previously held positions at Philip Morris.

Celsion ​has named Sid Taubenfeld ​as director of communications and strategic initiatives. Taubenfeld has spent the past 11 years working at three Wall Street funds.

Richard Freer ​has been appointed as CEO of Commonwealth Biotechnologies, Inc​ (CBI​). Freer was one of the founders of the company and has now replaced Bill Guo​ as CEO.

Aesica ​has hired Scott Silaika ​as business development director for the Eastern US. Silaika has 14 years of biopharm experience, most recently at Ricerca Biosciences.

Daniel Kisner ​has been appointed to the board of directors at Dynavax Technologies​. Kisner has previously worked Abbott Laboratories, Caliper Technologies and Isis Pharmaceuticals.

Adeona Pharmaceuticals ​has named Julie Caudill ​as VP of finance and corporate controller. For the past 15 years Caudill has worked at Aastrom Biosciences.

Related topics Markets & Regulations

Related news

Show more

Follow us


View more